XRTX - XORTX Announces Participation at Upcoming Investor Conferences | Benzinga
CALGARY, Alberta, Sept. 11, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that Dr. Allen Davidoff, President and CEO, is scheduled to participate in the following upcoming investor conferences:
H.C. Wainwright 25th Annual Global Investment Conference, New York City - September 11-13, 2023
Registration: XORTX Therapeutics Inc. to Present at the H.C. Wainwright 25th Annual Global Investment Conference September 11-13
Singular Research's Autumn Equinox Webinar on September 13-14
Registration: XORTX Therapeutics Inc. to Present at Singular Research's Autumn Equinox Webinar September 13th at 10:00 AM PST
The LD Micro Main Event XVI, Los Angeles– October 3 - 5
Registration: XORTX Therapeutics Inc. to Present at the LD Micro Main Event XVI in L.A. Wed, Oct 4 at 1:00-1:25 PM in Track 2 PST
Live Stream Registration: here
GCFF Conference ...